Comparison
22q Partial Monosomy C0265489 vs 14q11 2 Microduplication Syndrome C4749855
Clinical comparison between 22q Partial Monosomy and 14q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
22q Partial Monosomy C0265489
A genetic disorder from missing material on chromosome 22, often called DiGeorge syndrome. It can affect the heart, immune system, and development. Requires lifelong specialized medical care.
14q11 2 Microduplication Syndrome C4749855
A rare genetic condition involving a small extra piece of chromosome 14. Features vary and may include developmental delays. Management focuses on supportive therapies and monitoring.
6 comparison axes
Onset
22q Partial Monosomy C0265489
0-null
14q11 2 Microduplication Syndrome C4749855
0-5
Onset patterns differ
Severity
22q Partial Monosomy C0265489
severe
14q11 2 Microduplication Syndrome C4749855
moderate
Different severity levels
Chronic
22q Partial Monosomy C0265489
Chronic
14q11 2 Microduplication Syndrome C4749855
Chronic
Differing course
Communicable
22q Partial Monosomy C0265489
No
14q11 2 Microduplication Syndrome C4749855
No
Different transmission
Body System
22q Partial Monosomy C0265489
congenital
14q11 2 Microduplication Syndrome C4749855
congenital
Same/different system
Category
22q Partial Monosomy C0265489
rare-disease
14q11 2 Microduplication Syndrome C4749855
genetic
Different category
Bottom line
22q-partial-monosomy-C0265489 and 14q11-2-microduplication-syndrome-C4749855 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 22q Partial Monosomy C0265489 | 14q11 2 Microduplication Syndrome C4749855 | Discriminating power |
|---|---|---|---|
| Developmental concerns | Developmental differences may occur and can be substantial. | Developmental delay may occur, but the pattern is variable. | Moderate |
| Congenital anomalies | Heart, immune, or other anomalies may occur depending on the deleted region. | No single anomaly is established from the supplied description. | Moderate |
| Timing of recognition | May be suspected at birth, although onset data are incomplete. | Often considered between birth and age 5 when delays appear. | Low |
When to favor each condition
Choose 22q Partial Monosomy C0265489 when
Confirmed missing chromosome 22 material
The finding directly supports the left genetic category.
High
Severe congenital multisystem presentation
The supplied severity is severe, but symptoms alone are not diagnostic.
Moderate
Heart or immune concerns with developmental differences
These areas are described as possible features of 22q partial monosomy.
Moderate
Choose 14q11 2 Microduplication Syndrome C4749855 when
Confirmed extra material at 14q11.2
The duplication itself defines the right condition.
High
Variable developmental delay without a characteristic pattern
The source emphasizes variable features and supportive care.
Moderate
Evaluation during early childhood
The supplied onset range is 0–5 years, but timing varies.
Low
How key tests differ
| Test | 22q Partial Monosomy C0265489 | 14q11 2 Microduplication Syndrome C4749855 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show loss of chromosome 22 material within assay resolution. | May show gain at 14q11.2. | An abnormal result supports a copy-number finding but needs clinical correlation. |
| Targeted FISH or locus testing | May confirm a selected 22q deletion if probes match. | Useful only when specifically designed for 14q11.2. | A negative targeted test does not exclude every copy-number change. |
| Clinical and organ assessment | Heart, immune, growth, and development may need evaluation. | Assessment is individualized, often centered on development. | Testing guides care but does not establish a fixed prognosis. |
Prognosis comparison
22q Partial Monosomy C0265489
- Outcome
- Often chronic and potentially severe, but individual outcome is not established.
- Factors
- Deleted region, congenital anomalies, immune or heart involvement, and care access.
14q11 2 Microduplication Syndrome C4749855
- Outcome
- Often moderate and variable; long-term outcome is not established.
- Factors
- Duplication extent, developmental profile, and associated findings.
Time frame: Lifelong, with needs changing across development.
The precise genetic result and clinical assessment matter more than the label.
Complications comparison
| Complication | Presentation |
|---|---|
| Medical complexity | May involve cardiac, immune, and developmental needs. Specific complications are not established here. Risk should not be assumed equal between the conditions. |
| Developmental support | Support needs may be substantial. Therapy needs vary with the individual profile. Early developmental assessment is reasonable for both. |
| Long-term coordination | Specialized follow-up may be lifelong. Monitoring and supportive care vary in intensity. Plans should follow the confirmed genetic result and findings. |
Patient education highlights
- HighResult versus diagnosis
A chromosomal finding requires confirmation and interpretation; it does not by itself predict outcome.
- HighVariability
Effects depend on the exact region, size, genes involved, and other clinical findings.
- MediumFollow-up
Ask about genetic counseling, developmental surveillance, and organ checks when clinically indicated.